DrugPatentWatch Database Preview
Methylprednisolone sodium succinate - Generic Drug Details
Join the DrugPatentWatch Referral Program Get access to a free drug patent landscape report or a free one-month subscription
What are the generic sources for methylprednisolone sodium succinate and what is the scope of patent protection?
Methylprednisolone sodium succinate
is the generic ingredient in four branded drugs marketed by Abbott, Hospira, Hospira Inc, Elkins Sinn, Organon Usa Inc, Abraxis Pharm, Amneal Pharms Co, Aurobindo Pharma Ltd, Bedford Labs, Fresenius Kabi Usa, Hikma, Intl Medication, Sagent Pharms Inc, Teva Parenteral, Watson Labs, and Pharmacia And Upjohn, and is included in forty-seven NDAs. Additional information is available in the individual branded drug profile pages.There are forty drug master file entries for methylprednisolone sodium succinate. Thirteen suppliers are listed for this compound.
Summary for methylprednisolone sodium succinate
| US Patents: | 0 |
| Tradenames: | 4 |
| Applicants: | 16 |
| NDAs: | 47 |
| Drug Master File Entries: | 40 |
| Suppliers / Packagers: | 13 |
| Bulk Api Vendors: | 70 |
| Clinical Trials: | 15 |
| Patent Applications: | 4,307 |
| Formulation / Manufacturing: | see details |
| DailyMed Link: | methylprednisolone sodium succinate at DailyMed |
Recent Clinical Trials for methylprednisolone sodium succinate
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Children's Hospital of Fudan University | Phase 3 |
| Taipei Medical University WanFang Hospital | Phase 2/Phase 3 |
| Azienda Policlinico Umberto I | Phase 3 |
Pharmacology for methylprednisolone sodium succinate
| Drug Class | Corticosteroid |
| Mechanism of Action | Corticosteroid Hormone Receptor Agonists |
Synonyms for methylprednisolone sodium succinate
| (2R)-2-Mercaptomethyl-4-methylpentanoyl-Phe-Ala amide |
| (6alpha,11beta)-21-(3-Carboxy-1-oxopropoxy)-11,17-dihydroxy-6-methyl-Pregna-1,4-diene-3,20-dione monosodium salt |
| 1,4-pregnadien-6-alpha-methyl-11-beta, 17,21-triol-3,20-dione 21-succinate, sodium salt |
| 11-beta,17,21-Trihydroxy-6-alpha-methyl-1,4-pregnadiene-3,20-dione 21-(sodium succinate) |
| 11-beta,17,21-trihydroxy-6-alpha-methyl-1,4-pregnadiene-3,20-dione21-(sodium |
| 11beta,17,21-Trihydroxy-6alpha-methylpregna-1,4-diene-3,20-dione 21-(hydrogen succinate) |
| 11beta,17,21-Trihydroxy-6alpha-methylpregna-1,4-diene-3,20-dione 21-(sodium succinate) |
| 2375-03-3 |
| 2375-03-3 (mono-hydrochloride salt) |
| 2921-57-5 |
| 2921-57-5 (Parent) |
| 375M033 |
| 4-(2-((6S,8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-6,10,13-trimethyl-3-oxo-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-17-yl)-2-oxoethoxy)-4-oxobutanoic acid |
| 4-[2-(11,17-dihydroxy-6,10,13-trimethyl-3-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-yl)-2-oxoethoxy]-4-oxobutanoate |
| 4-[2-[(6S,8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-6,10,13-trimethyl-3-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-yl]-2-oxoethoxy]-4-oxobutanoic acid |
| 4-oxidanylidene-4-[2-oxidanylidene-2-[(6S,8S,9S,10R,11S,13S,14S,17R)-6,10,13-trimethyl-11,17-bis(oxidanyl)-3-oxidanylidene-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-yl]ethoxy]butanoic acid |
| 5GMR90S4KN |
| 6-alpha-Methylprednisolone sodium succinate |
| 6-Methylprednisolone 21-hemisuccinate sodium salt |
| 6.alpha.-Methylprednisolone 21-hemisuccinate sodium salt |
| 6.alpha.-Methylprednisolone 21-sodium hemisuccinate |
| 6.alpha.-Methylprednisolone 21-sodium succinate |
| 6.alpha.-Methylprednisolone sodium hemisuccinate |
| 6.alpha.-Methylprednisolone sodium succinate |
| 6.alpha.-Methylpregnisolone 21-sodium succinate |
| 6|A-Methyl-11|A,17|A,21-trihydroxy-1,4-pregnadiene-3,20-dione 21-hemisuccinate |
| 6|A-Methylprednisolone 21-hemisuccinate (sodium salt) |
| 6|A-Methylprednisolone 21-hemisuccinate Sodium |
| 6|A-Methylprednisolone 21-hemisuccinate sodium salt |
| 6A-methylprednisolone 21-hemisuccinate*sodium |
| 6a-Methylprednisolone 21-succinate sodium |
| 6AfAE'A centa' notA inverted exclamation markAfasA'A|AfAE'Adaggeratrade mark?-Methylprednisolone 21-hemisuccinate (sodium salt) |
| 6alpha-Methyl-11beta,17alpha,21-trihydroxy-1,4-pregnadiene-3,20-dione 21-hemisuccinate |
| 6alpha-methyl-11beta,17alpha,21-trihydroxy-1,4-pregnadiene-3,20-dione 21-hemisuccinate sodium salt |
| 6alpha-Methylprednisolone 21-hemisuccinate |
| 6alpha-Methylprednisolone 21-hemisuccinate sodium salt |
| 6alpha-Methylprednisolone 21-hemisuccinate sodium salt, lyophilized powder |
| 6alpha-Methylprednisolone 21-sodium hemisuccinate |
| 6alpha-Methylprednisolone 21-sodium succinate |
| 6alpha-Methylprednisolone hemisuccinate |
| 6alpha-Methylprednisolone sodium hemisuccinate |
| 6alpha-Methylprednisolone sodium succinate |
| 6alpha-Methylpregnisolone 21-sodium succinate |
| 6I+/--Methylprednisolone 21-hemisuccinate sodium salt |
| 921M575 |
| A-methapred (TN) |
| A819819 |
| AB00053696_02 |
| AC1L28YL |
| AC1NO89B |
| AJ-47556 |
| AK-94859 |
| AKOS015894899 |
| AKOS015962276 |
| AKOS016011114 |
| AN-14230 |
| Asmacortone |
| AX8105809 |
| C-22742 |
| C26H33O8.Na |
| C26H34O8 |
| CAS-2375-03-3 |
| CCG-213144 |
| CHEBI:135765 |
| CHEBI:6890 |
| CHEMBL1201081 |
| CHEMBL1201265 |
| Corticel |
| Cryosolona |
| Cryosolona [inj.] |
| CS-4582 |
| CS-8183 |
| CTK8G1090 |
| D00751 |
| D05000 |
| DSSTox_CID_3303 |
| DSSTox_GSID_23303 |
| DSSTox_RID_76967 |
| DTXSID2023303 |
| DTXSID80183466 |
| EC 220-863-9 |
| EINECS 219-156-8 |
| EINECS 220-863-9 |
| Emmetipi |
| Firmacort Fiale |
| FQISKWAFAHGMGT-SGJOWKDISA-M |
| HMS2093A09 |
| HY-B1060 |
| HY-B1900 |
| I038 |
| LEC9GKY20K |
| Lemod Solu |
| LS-118430 |
| LS-118507 |
| M-6-P |
| Medrate [inj.] |
| Meghylprednisolone hemisuccinate |
| methprednisolone sodium succinate |
| Methylprednisolone 21-(hydrogen succinate) |
| METHYLPREDNISOLONE HEMISUCCINATE |
| Methylprednisolone hemisuccinate (USP) |
| Methylprednisolone Hemisuccinate [USP] |
| Methylprednisolone Hemisuccinate Monosodium Salt |
| Methylprednisolone hydrogen succinate |
| Methylprednisolone Hydrogen Succinate Sodium Salt |
| Methylprednisolone sodium hemisuccinate |
| Methylprednisolone sodium succinate (JAN/USP) |
| Methylprednisolone Sodium Succinate (methylprednisolone 21-(hydrogen succinate)) |
| Methylprednisolone Sodium Succinate [USAN:JAN] |
| Methylprednisolone sodium succinate [USP:JAN] |
| Methylprednisolone succinate |
| Methylprednisolone succinate (JP17) |
| Methylprednisolone succinate sodium salt |
| Metypred |
| Metypred [inj.] |
| Metypresol |
| MFCD00152612 |
| MolPort-005-935-240 |
| MolPort-006-114-238 |
| NCGC00185763-01 |
| Nirypan solubile |
| NSC 48989 |
| NSC-48989 |
| NSC-758428 |
| NSC48989 |
| NSC758428 |
| Omnacortil |
| Pharmakon1600-01503255 |
| Prednilem |
| Prednisolone, 6alpha-methyl-, succinate, sodium salt |
| Prednisolone, succinate, sodium salt |
| Prednol |
| Prednol [inj.] |
| Pregna-1,20-dione, 11.beta.,17,21-trihydroxy-6.alpha.-methyl-, 21-(hydrogen succinate), monosodium salt |
| Pregna-1,20-dione, 21-(3-carboxy-1-oxopropoxy)-11,17-dihydroxy-6-methyl-, monosodium salt, (6.alpha.,11.beta.)- |
| Pregna-1,4-diene-3,20-dione, 11-beta,17,21-trihydroxy-6-alpha-methyl-, 21- (hydrogen succinate), monosodium salt |
| Pregna-1,4-diene-3,20-dione, 11-beta,17,21-trihydroxy-6-alpha-methyl-, 21-(hydrogen succinate), monosodium salt |
| Pregna-1,4-diene-3,20-dione, 11beta,17,21-trihydroxy-6alpha-methyl-, 21-(hydrogen succinate), monosodium salt |
| Pregna-1,4-diene-3,20-dione, 11beta,17,21-trihydroxy-6alpha-methyl-, 21-(hydrogen succinate), monosodium salt (8CI) |
| Pregna-1,4-diene-3,20-dione, 21-(3-carboxy-1-oxopropoxy)-11,17-dihydroxy-6-methyl-, (6alpha,11beta)- |
| Pregna-1,4-diene-3,20-dione, 21-(3-carboxy-1-oxopropoxy)-11,17-dihydroxy-6-methyl-, monosodium salt, (6alpha,11beta)- |
| Pregna-1,4-diene-3,20-dione, 21-(3-carboxy-1-oxopropoxy)-11,17-dihydroxy-6-methyl-,(6-alpha,11-beta)- |
| Pregna-1,4-diene-3,20-dione,21-(3-carboxy-1-oxopropoxy)-11,17-dihydroxy-6-methyl-, (6a,11b)- |
| SCHEMBL40947 |
| SCHEMBL7915 |
| sodium 4-[2-[(6S,8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-6,10,13-trimethyl-3-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-yl]-2-oxo-ethoxy]-4-oxo-butanoate |
| sodium 4-{[(6alpha,11beta)-11,17-dihydroxy-6-methyl-3,20-dioxopregna-1,4-dien-21-yl]oxy}-4-oxobutanoate |
| Sodium methylprednisolone succinate |
| sodium;4-[2-[(6S,8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-6,10,13-trimethyl-3-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-yl]-2-oxoethoxy]-4-oxobutanoate |
| Sol Melcort |
| Solu Medrol |
| Solu-Medrol |
| Solu-medrol (TN) |
| Solu-Medrone |
| Solumedrol |
| SR-05000002140 |
| SR-05000002140-1 |
| Succinic acid, 21-monoester with 11beta,17,21-trihydroxy-6alpha-methylpregna-1,4-diene-3,20-dione, monosodium salt |
| Tox21_113527 |
| U 9088 |
| Ubrason solubile |
| Ubrason solubile [inj.] |
| UNII-5GMR90S4KN |
| UNII-LEC9GKY20K |
| Urabason |
| Urbason solubile |
| Urbason-Soluble |
| W-107376 |
| ZINC3977781 |
US Patents and Regulatory Information for methylprednisolone sodium succinate
Make Better Decisions: Try a trial or see plans & pricing
Serving leading biopharmaceutical companies globally:
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Copyright 2002-2019 thinkBiotech LLC
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Major Patent Expirations 2019 - 2020
NCE-1 Patent Challenge Dates 2019 - 2020
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Major Patent Expirations 2019 - 2020
NCE-1 Patent Challenge Dates 2019 - 2020
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2019, www.DrugPatentWatch.com.